Drug for common childhood virus RSV cuts symptoms

Embargoed until: Publicly released: 2022-02-17 09:00

International

A new drug has been shown to help reduce cold and flu-like symptoms caused by the respiratory syncytial virus (RSV) after healthy volunteers were deliberately infected and then treated with the drug. RSV is a common virus that infects the airways and lungs and it is often seen in kids under five. The drug, known as EDP-938, stops the virus from replicating. In the study, those who received the drug had less virus detected in their system, and fewer symptoms than those who received a placebo, while the side effects were similar. An accompanying editorial cautions that positive results from studies such as this are not always followed by success in later clinical trials.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Editorial / Opinion Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Enanta Pharmaceuticals

Funder: Enanta Pharmaceuticals

Media Contact/s

Contact details are only visible to registered journalists.